News
-
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
First Study Site Established for Jaguar Health Study of its FDA Conditionally Approved Canalevia-CA1 Prescription Drug for Dogs
Jaguar Health, Inc. announces goals to expand crofelemer usage from chemotherapy-induced to general diarrhea treatment in dogs. Research studies and partnerships in progress -
COMMUNIQUÉ DE PRESSE
Rapport annuel CEMP Exercice 2024
-
-
-